JGC
ARKG icon

J. Goldman & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

J. Goldman & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,415
Closed -$225K – 432
2020
Q4 		$225K Buy
+2,415
New +$192K 0.01% 326

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

J. Goldman & Co's ARKG Position: Q1 2021 in Review

J. Goldman & Co sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 2,415 shares — an estimated $225K sold.

J. Goldman & Co first reported a position in ARKG in Q4 2020 and held it in 1 quarter. The position peaked at $225K in Q4 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • J. Goldman & Co reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • J. Goldman & Co sold 2,415 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $225K.
  • J. Goldman & Co first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 1 quarter.
  • J. Goldman & Co's ARK Genomic Revolution ETF position peaked at $225K in Q4 2020.
  • 505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on J. Goldman & Co's 13F filing for Q1 2021, filed 17 May 2021.